BioSpace News Archive

Perimeter Medical Imaging AI, Inc. is providing a further update on the status of the filing of its interim financial statements for its first quarter ending March 31, 2020.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the U.S. Food and Drug Administration (FDA) has approved Evrysdi™ (risdiplam), the first at-home, orally administered treatment for spinal muscular atrophy (SMA) in adults and children 2 months and older.

Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that it will host a conference call and live webcast at 8:30 a.m. ET, Thursday, August 13, 2020 to report its second quarter 2020 financial results and discuss recent business highlights. To access the live conference call, please dial 833-528-0605 (domestic) or 830-22

Emergent BioSolutions Inc. (NYSE:EBS) (the “Company”) announced today that it has completed its previously announced offering of $450 million in aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028 (the “Notes”). The Notes are fully and unconditionally guaranteed on a senior unsecured basis by all of the Company’s direct and indirect subsidiaries that guarantee debt under its credit facilities. The Company has used the

Mirum Pharmaceuticals to Present at the Canaccord Genuity 40 th Annual Growth Conference

Veracyte, Inc. announced the closing of its public offering of 6,900,000 shares of common stock, including 900,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $30.00 per share.

Flexion Therapeutics, Inc. announced equity inducement grants to two new employees consisting of 25,315 restricted stock units.

MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference 2020 on Tuesday, August 11, 2020 at 2:00 pm.